New chemotherapy agents in the treatment of advanced non-small cell lung cancer: An update including data from the seventh world conference on lung cancer
- 1 June 1995
- journal article
- review article
- Published by Elsevier in Lung Cancer
- Vol. 12, S63-S99
- https://doi.org/10.1016/s0169-5002(10)80007-8
Abstract
No abstract availableKeywords
This publication has 68 references indexed in Scilit:
- Phase II study with paclitaxel in advanced inoperable non-small cell lung cancer (NSCLC)—The European experienceLung Cancer, 1994
- Phase I study of epirubicin plus vinorelbine with or without G-CSF in advanced non-small cell lung cancerEuropean Journal Of Cancer, 1993
- Polychemotherapy in advanced non small cell lung cancer: a meta-analysisThe Lancet, 1993
- Phase II study of high-dose epirubicin and etoposide in advanced non-small cell lung cancerEuropean Journal Of Cancer, 1992
- Autocrine growth stimulation by transforming growth factor-α in human non-small cell lung cancerSurgical Oncology, 1992
- Activity of high-dose epirubicin in advanced non-small cell lung cancerEuropean Journal of Cancer and Clinical Oncology, 1991
- Phase II study of high-dose epirubicin in non-small cell lung cancerEuropean Journal of Cancer and Clinical Oncology, 1990
- TGF-β stimulation and inhibition of cell proliferation: New mechanistic insightsCell, 1990
- Chemotherapy in the Treatment of Non-Small Cell Lung CancerCancer Investigation, 1986
- Phase II trial of epirubicin in advanced squamous, adeno- and large cell carcinoma of the lungEuropean Journal of Cancer and Clinical Oncology, 1984